{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:01:56Z","timestamp":1787065316520,"version":"build-2736575974"},"posted":{"date-parts":[[2021,3,22]]},"group-title":"Immunology","reference-count":83,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                <jats:p>\n                  Neutralizing antibodies (NAbs) are effective in treating COVID-19 but the mechanism of immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) to monitor the real-time effects of NAb treatment in prophylaxis and therapy of K18-hACE2 mice intranasally infected with SARS-CoV-2-nanoluciferase. We could visualize virus spread sequentially from the nasal cavity to the lungs and thereafter systemically to various organs including the brain, which culminated in death. Highly potent NAbs from a COVID-19 convalescent subject prevented, and also effectively resolved, established infection when administered within three days. In addition to direct Fab-mediated neutralization, Fc effector interactions of NAbs with monocytes, neutrophils and natural killer cells were required to effectively dampen inflammatory responses and limit immunopathology. Our study highlights that both Fab and Fc effector functions of NAbs are essential for optimal\n                  <jats:italic>in vivo<\/jats:italic>\n                  efficacy against SARS-CoV-2.\n                <\/jats:p>","DOI":"10.1101\/2021.03.22.436337","type":"posted-content","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T18:55:15Z","timestamp":1616439315000},"source":"Crossref","is-referenced-by-count":19,"title":["Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-8693","authenticated-orcid":false,"given":"Irfan","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Pr\u00e9vost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-3513","authenticated-orcid":false,"given":"Mark S","family":"Ladinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-5079","authenticated-orcid":false,"given":"Helen","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-6447","authenticated-orcid":false,"given":"Maolin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-8259","authenticated-orcid":false,"given":"Sai Priya","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8092-4101","authenticated-orcid":false,"given":"Guillaume","family":"Beaudoin-Bussi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-8442","authenticated-orcid":false,"given":"Kelly","family":"Symmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Benlarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-1106","authenticated-orcid":false,"given":"Romain","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corby","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9153-3600","authenticated-orcid":false,"given":"Alexandra","family":"Tauzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-568X","authenticated-orcid":false,"given":"Guillaume","family":"Goyette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bourassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Medjahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2495-9403","authenticated-orcid":false,"given":"Craig B","family":"Wilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Dekaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-5395","authenticated-orcid":false,"given":"Jimmy D.","family":"Dikeakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-7097","authenticated-orcid":false,"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-6859","authenticated-orcid":false,"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-9589","authenticated-orcid":false,"given":"Jonathan","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5057","authenticated-orcid":false,"given":"Marzena","family":"Pazgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-3990","authenticated-orcid":false,"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-7240","authenticated-orcid":false,"given":"Walther","family":"Mothes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-5288","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Finzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-5601","authenticated-orcid":false,"given":"Priti","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7236-858X","authenticated-orcid":false,"given":"Pradeep D.","family":"Uchil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024080516485458000_2021.03.22.436337v2.1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000583"},{"key":"2024080516485458000_2021.03.22.436337v2.2","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.108"},{"key":"2024080516485458000_2021.03.22.436337v2.3","doi-asserted-by":"crossref","unstructured":"Anand, S.P. , Prevost, J. , Nayrac, M. , Beaudoin-Bussieres, G. , Benlarbi, M. , Gasser, R. , Brassard, N. , Laumaea, A. , Gong, S.Y. , Bourassa, C. , et al. (2021a). Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. bioRxiv 2021.01.25.428097.","DOI":"10.1101\/2021.01.25.428097"},{"key":"2024080516485458000_2021.03.22.436337v2.4","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16318"},{"key":"2024080516485458000_2021.03.22.436337v2.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe2402"},{"key":"2024080516485458000_2021.03.22.436337v2.6","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02590-02520"},{"key":"2024080516485458000_2021.03.22.436337v2.7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06048-11"},{"key":"2024080516485458000_2021.03.22.436337v2.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911842116"},{"key":"2024080516485458000_2021.03.22.436337v2.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.023"},{"key":"2024080516485458000_2021.03.22.436337v2.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.003"},{"key":"2024080516485458000_2021.03.22.436337v2.11","doi-asserted-by":"crossref","unstructured":"Carossino, M. , Montanaro, P. , O\u2019Connell, A. , Kenney, D. , Gertje, H. , Grosz, K.A. , Kurnick, S.A. , Bosmann, M. , Saeed, M. , Balasuriya, U.B.R. , et al. (2021). Fatal neuroinvasion of SARS-CoV-2 in K18-hACE2 mice is partially dependent on hACE2 expression. bioRxiv, 2021.2001.2013.425144.","DOI":"10.1101\/2021.01.13.425144"},{"key":"2024080516485458000_2021.03.22.436337v2.12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"2024080516485458000_2021.03.22.436337v2.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf6840"},{"key":"2024080516485458000_2021.03.22.436337v2.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2708-8"},{"key":"2024080516485458000_2021.03.22.436337v2.15","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1323159"},{"key":"2024080516485458000_2021.03.22.436337v2.16","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","year":"2020","journal-title":"Nat Med"},{"key":"2024080516485458000_2021.03.22.436337v2.17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3443"},{"key":"2024080516485458000_2021.03.22.436337v2.18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.1109.1108.287482"},{"key":"2024080516485458000_2021.03.22.436337v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30221-0"},{"key":"2024080516485458000_2021.03.22.436337v2.20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.614256"},{"key":"2024080516485458000_2021.03.22.436337v2.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.01.003"},{"key":"2024080516485458000_2021.03.22.436337v2.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.02.012"},{"key":"2024080516485458000_2021.03.22.436337v2.23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142032"},{"key":"2024080516485458000_2021.03.22.436337v2.24","doi-asserted-by":"crossref","unstructured":"Gorman, M.J. , Patel, N. , Guebre-Xabier, M. , Zhu, A. , Atyeo, C. , Pullen, K.M. , Loos, C. , Goez-Gazi, Y. , Carrion, R. , Tian, J.-H. , et al. (2021). Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M\u2122 vaccination. bioRxiv, 2021.2002.2005.429759.","DOI":"10.1101\/2021.02.05.429759"},{"key":"2024080516485458000_2021.03.22.436337v2.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.016"},{"key":"2024080516485458000_2021.03.22.436337v2.26","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/infdis\/jiaa518","article-title":"COVID-19 Vaccines: Should We Fear ADE?","volume":"222","year":"2020","journal-title":"The Journal of infectious diseases"},{"key":"2024080516485458000_2021.03.22.436337v2.27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0827"},{"key":"2024080516485458000_2021.03.22.436337v2.28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies","volume":"182","year":"2020","journal-title":"Cell"},{"key":"2024080516485458000_2021.03.22.436337v2.29","doi-asserted-by":"publisher","DOI":"10.1038\/nature07255"},{"key":"2024080516485458000_2021.03.22.436337v2.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2024080516485458000_2021.03.22.436337v2.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072942"},{"key":"2024080516485458000_2021.03.22.436337v2.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409465102"},{"key":"2024080516485458000_2021.03.22.436337v2.33","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826"},{"key":"2024080516485458000_2021.03.22.436337v2.34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2024080516485458000_2021.03.22.436337v2.35","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.23.436684"},{"key":"2024080516485458000_2021.03.22.436337v2.36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","year":"2020","journal-title":"Mucosal Immunol"},{"key":"2024080516485458000_2021.03.22.436337v2.37","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3769"},{"key":"2024080516485458000_2021.03.22.436337v2.38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","year":"2020","journal-title":"Nature"},{"key":"2024080516485458000_2021.03.22.436337v2.39","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57877"},{"key":"2024080516485458000_2021.03.22.436337v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19619-7"},{"key":"2024080516485458000_2021.03.22.436337v2.41","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E12-02-0093"},{"key":"2024080516485458000_2021.03.22.436337v2.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.050"},{"key":"2024080516485458000_2021.03.22.436337v2.43","doi-asserted-by":"crossref","unstructured":"Leist, S.R. , Sch\u00e4fer, A. , and Martinez, D.R . (2020b). Cell and animal models of SARS-CoV-2 pathogenesis and immunity. Disease Models & Mechanisms 13, dmm046581.","DOI":"10.1242\/dmm.046581"},{"key":"2024080516485458000_2021.03.22.436337v2.44","doi-asserted-by":"crossref","unstructured":"Li, D. , Edwards, R.J. , Manne, K. , Martinez, D.R. , Sch\u00e4fer, A. , Alam, S.M. , Wiehe, K. , Lu, X. , Parks, R. , Sutherland, L.L. , et al. (2021). The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates. bioRxiv, 2020.2012.2031.424729.","DOI":"10.1101\/2020.12.31.424729"},{"key":"2024080516485458000_2021.03.22.436337v2.45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010197117"},{"key":"2024080516485458000_2021.03.22.436337v2.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2571-7"},{"key":"2024080516485458000_2021.03.22.436337v2.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.08.015"},{"key":"2024080516485458000_2021.03.22.436337v2.48","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.106"},{"key":"2024080516485458000_2021.03.22.436337v2.49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-019-1101-y","article-title":"Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET","volume":"568","year":"2019","journal-title":"Nature"},{"key":"2024080516485458000_2021.03.22.436337v2.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.11.001"},{"key":"2024080516485458000_2021.03.22.436337v2.51","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","article-title":"Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice","volume":"166","year":"2001","journal-title":"The Journal of Immunology"},{"key":"2024080516485458000_2021.03.22.436337v2.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2005.07.007"},{"key":"2024080516485458000_2021.03.22.436337v2.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2818.2008.01977.x"},{"key":"2024080516485458000_2021.03.22.436337v2.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2016.07.011"},{"key":"2024080516485458000_2021.03.22.436337v2.55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02012-06"},{"key":"2024080516485458000_2021.03.22.436337v2.56","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254426"},{"key":"2024080516485458000_2021.03.22.436337v2.57","doi-asserted-by":"crossref","unstructured":"Noy-Porat, T. , Mechaly, A. , Levy, Y. , Makdasi, E. , Alcalay, R. , Gur, D. , Aftalion, M. , Falach, R. , Ben-Arye, S.L. , Lazar, S. , et al. (2021). Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. bioRxiv, 2021.2002.2002.428995.","DOI":"10.1101\/2021.02.02.428995"},{"key":"2024080516485458000_2021.03.22.436337v2.58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1608147113"},{"key":"2024080516485458000_2021.03.22.436337v2.59","doi-asserted-by":"crossref","unstructured":"Prevost, J. , Gasser, R. , Beaudoin-Bussieres, G. , Richard, J. , Duerr, R. , Laumaea, A. , Anand, S.P. , Goyette, G. , Benlarbi, M. , Ding, S. , et al. (2020). Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell Rep Med 1, 100126.","DOI":"10.1016\/j.xcrm.2020.100126"},{"key":"2024080516485458000_2021.03.22.436337v2.60","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc7520"},{"key":"2024080516485458000_2021.03.22.436337v2.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.007"},{"key":"2024080516485458000_2021.03.22.436337v2.62","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fimmu.2019.01296","article-title":"Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life","volume":"10","year":"2019","journal-title":"Front Immunol"},{"key":"2024080516485458000_2021.03.22.436337v2.63","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-021-00596-4"},{"key":"2024080516485458000_2021.03.22.436337v2.64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201993"},{"key":"2024080516485458000_2021.03.22.436337v2.65","doi-asserted-by":"publisher","DOI":"10.21203\/rs.21203.rs-70482\/v21201"},{"key":"2024080516485458000_2021.03.22.436337v2.66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","year":"2020","journal-title":"Nature"},{"key":"2024080516485458000_2021.03.22.436337v2.67","doi-asserted-by":"crossref","unstructured":"Silvas, J. , Morales-Vasquez, D. , Park, J.-G. , Chiem, K. , Torrelles, J.B. , Platt, R.N. , Anderson, T. , Ye, C. , and Martinez-Sobrido, L. (2021). Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice. bioRxiv, 2021.2003.2009.434696.","DOI":"10.1101\/2021.03.09.434696"},{"key":"2024080516485458000_2021.03.22.436337v2.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203954109"},{"key":"2024080516485458000_2021.03.22.436337v2.69","unstructured":"Stamatatos, L. , Czartoski, J. , Wan, Y.-H. , Homad, L.J. , Rubin, V. , Glantz, H. , Neradilek, M. , Seydoux, E. , Jennewein, M.F. , MacCamy, A.J. , et al. (2021). Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1. medRxiv, 2021.2002.2005.21251182."},{"key":"2024080516485458000_2021.03.22.436337v2.70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030237"},{"key":"2024080516485458000_2021.03.22.436337v2.71","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe3354"},{"key":"2024080516485458000_2021.03.22.436337v2.72","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd5223"},{"key":"2024080516485458000_2021.03.22.436337v2.73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008161"},{"key":"2024080516485458000_2021.03.22.436337v2.74","doi-asserted-by":"publisher","DOI":"10.1101\/2020.1112.1120.423708"},{"key":"2024080516485458000_2021.03.22.436337v2.75","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2035002"},{"key":"2024080516485458000_2021.03.22.436337v2.76","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","year":"2020","journal-title":"Nature immunology"},{"key":"2024080516485458000_2021.03.22.436337v2.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.1002.1026"},{"key":"2024080516485458000_2021.03.22.436337v2.78","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An Infectious cDNA Clone of SARS-CoV-2","volume":"27","year":"2020","journal-title":"Cell Host Microbe"},{"key":"2024080516485458000_2021.03.22.436337v2.79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19055-7"},{"key":"2024080516485458000_2021.03.22.436337v2.80","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular Architecture of the SARS-CoV-2 Virus","volume":"183","year":"2020","journal-title":"Cell"},{"key":"2024080516485458000_2021.03.22.436337v2.81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-41020-19808-41464"},{"key":"2024080516485458000_2021.03.22.436337v2.82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","year":"2020","journal-title":"Nature"},{"key":"2024080516485458000_2021.03.22.436337v2.83","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","year":"2020","journal-title":"Nature medicine"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.03.22.436337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:28:30Z","timestamp":1768440510000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2021.03.22.436337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":83,"URL":"https:\/\/doi.org\/10.1101\/2021.03.22.436337","relation":{},"subject":[],"published":{"date-parts":[[2021,3,22]]},"subtype":"preprint"}}